PTK2 and colorectal carcinoma: While FAK pharmacological inhibition combined with radiation radiosensitized HNSCC, it did not show any additional effect in vitro on ionizing radiation lethality in non-Kras mutated NSCLC, colorectal carcinoma, and pancreatic carcinoma cell lines [229].